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This study examined the acute immune and inflammatory responses to exercise in 
smokers compared to non-smokers, and further, the effect of smoking history on these 
immune-inflammatory responses. Fifty-four recreationally active males who were either 
smokers (SM; n = 27) or non-smokers (NS; n = 27) were allocated into either young 
(YSM, YNS) or middle-aged groups (MSM, MNS) based on smoking status. Participants 
were matched for fitness and smoking habits and following familiarization and baseline 
testing, undertook an exercise protocol that involved 40 min of cycle ergometry at 50% 
of VO2peak. Venous blood was obtained pre- and post- (0 min, 1, and 4 h) exercise to 
measure circulating leukocytes and inflammatory markers interleukin (IL)-6, IL-1β, IL-1ra, 
and monocyte chemoattractant protein-1 (MCP-1). Compared to MNS, MSM showed 
elevated basal concentrations of MCP-1, which were increased with a longer smok-
ing history (P <  0.05). In response to exercise, YSM demonstrated an amplified IL-6 
response from immediately- to 1 h-post compared to YNS. Furthermore, IL-1ra in YSM 
was elevated above that of YNS across all time points (P < 0.05). The MSM group had 
higher IL-1β at baseline when compared to YSM, although IL-1ra was greater for YSM 
at baseline (P < 0.05). Finally, the post-exercise leukocyte response was greater in MSM 
compared to YSM and non-smokers (P < 0.05). In conclusion, smoker’s exhibit elevated 
MCP-1 and IL-1β that seem to be evident with a longer smoking history (~15 years). 
Furthermore, the differences in exercise-induced inflammatory responses noted in YSM 
may be indicative tobacco smoke exposure priming circulating leukocytes to amplify 
inflammatory responses.
Keywords: cycling, cytokines, leukocytes, smokers, non-smokers
inTrODUcTiOn
Long-term tobacco smoking induces a myriad of inflammatory processes and alterations to the 
immune system, which in turn are key steps in the pathogenesis of cardiovascular disease (CVD), 
diabetes, and chronic obstructive pulmonary disease (COPD) (1–3). Specifically, long-term smok-
ing is reported to up-regulate pro-inflammatory cytokines, including interleukin (IL)-6, IL-1 
beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP). In turn, this 
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pro-inflammatory up-regulation results in the development of 
a low grade systemic inflammatory state, which presents as an 
independent risk factor for disease development (4–6). While 
immune and inflammatory changes are suggested to result from 
a lifetime of smoking (4, 5), the acute physiological outcomes 
of a shorter smoking history are unknown. Conversely, exercise 
is viewed as an effective regulator of immune function (7), 
particularly given its ability to promote an anti-inflammatory 
environment (8–10). Consequently, the exercise-induced anti-
inflammatory response may be beneficial for long-term smok-
ers, although research outlining this remains scarce. Given that 
immune and inflammatory changes associated with smoking are 
suggested to precede chronic disease development (2, 11), and 
exercise has been reported as an effective tool in meditating such 
developments (12, 13), it is pertinent to determine inflammatory 
responses to exercise in a smoker population.
While smoking induces both immunosuppressive and 
inflammatory effects resulting in the development of the 
aforementioned pathological states (1, 14), regular exercise 
is reported as an effective intervention for mediating disease 
risk (12, 13). While some exercise-induced physiological 
responses of smokers have been reported, including heart 
rate (HR), cardiovascular function, and oxygen consump-
tion (15–17), the immune-inflammatory parameters remain 
less well defined. In healthy non-smokers, an acute bout of 
exercise has been shown to result in augmented inflammatory 
cytokines, including IL-6, IL-1ra, and IL-10 with anti-inflam-
matory actions (12); the magnitude of which is dependent on 
modality, intensity, and duration (9). Thus, given the elevated 
pro-inflammatory state of smokers [IL-1β, monocyte chem-
oattractant protein-1 (MCP-1), and IL-6], coupled with the 
proposed anti-inflammatory response to moderate-intensity 
exercise (Il-1ra and IL-6), it remains unknown of the exercise 
response is blunted in smoking populations, or with prolonged 
smoking exposure.
Despite the well-known effects of exercise on immune and 
inflammatory regulation and the deleterious effect of long-term 
smoking, few have sort to investigate the effects of exercise in 
smokers who may exhibit altered immune responses. Flouris 
et al. (18) suggest that even brief exposure to second hand smoke 
(SHS) markedly reduced cardiorespiratory and immune vari-
ables following 30 min of moderate intensity exercise (18). Given 
that long-term smoking is associated with immunosuppression, 
increased inflammation, and thus greater susceptibility to disease 
development, it seems particularly important to examine the 
effects of the exercise-induced inflammatory response in smok-
ers. Furthermore, given the lack of longitudinal cohort data, 
the observed effect in those with relatively shorter compared 
to longer smoking histories also seems pertinent. That is, it is 
unknown whether smokers with a shorter smoking history pre-
sent the immune alterations as observed in long-term smokers, 
while still matching for factors that can affect inflammatory state, 
such as aerobic fitness. Therefore, this study aims to determine 
the acute immune and inflammatory responses to exercise in 
smokers compared to non-smokers. A secondary aim is to exam-
ine the effect of smoking history on the immune-inflammatory 
responses.
MaTerials anD MeThODs
Participants
The study population consisted of 54 recreationally active males 
who were either smokers (SM; n =  27) or non-smokers (NS; 
n =  27). Participants were allocated into either young (YSM, 
YNS) or middle-aged groups (MSM, MNS) based on the dura-
tion of their smoking status. In the current study, delimitations 
for age were presented, while a number of middle-aged smok-
ers were recruited, ~10 were excluded as they presented with 
pre-existing medical conditions and were not appropriate to 
participate in the study. Accordingly, participants reported as 
apparently healthy and free from any known metabolic, car-
diovascular, or pulmonary disease, immunological irregularities 
or other conditions associated with systemic inflammatory 
responses and no participants were taking any potentially con-
founding medications. Participants were matched for age and 
aerobic fitness, with anthropometric and descriptive baseline 
values reported in Table 1. The NS participants (YSM and MNS) 
were classified as never smokers and were otherwise healthy 
individuals who reported modest regular physical activity 
(2–3 days of 30 min/week). The smokers (YSM and MSM) were 
otherwise healthy individuals who were current active smokers. 
The self-reported smoking history for the SM population was 
5.2 ±  1.7  years of smoking and 12.3 ±  6.5  cigarettes/day for 
YSM and 14.6 ± 6.3 years of smoking and 15.8 ± 7.3 cigarettes/
day MSM. Smoking participants engaged in comparable levels 
of recreational physical activity as the non-smokers based on 
qualitative feedback regarding exercise engagement. Prior to 
the commencement of the study, all participants were required 
to provide written and verbal consent following an outline of 
all procedures and measures. This study conformed to the 
Declaration of Helsinki and was approved by the Research in 
Human Ethics Committee at the University.
study Overview
Prior to involvement, participants were required to undergo a 
medical screening, complete an adult pre-exercise screening sys-
tem (APSS), a healthy history questionnaire and the Fagerstrom 
test for nicotine dependence [FTND; (19)]. If participants satis-
fied the inclusion criteria, they were then enrolled in the study. A 
familiarization of all measures and procedures and then baseline 
testing sessions were conducted to obtain anthropometric and 
aerobic exercise capacity data (VO2peak). Following ~7  days’ 
rest, participants returned to the laboratory for a testing ses-
sion. Participants were required to cycle at 50% of VO2peak for 
the duration of 40  min. HR and rating of perceived exertion 
(RPE; Borg CR10 scale; Borg 1990) were collected throughout 
the 40 min. Additionally, a venous blood sample was obtained 
pre- and post- (0 min, 1, and 4 h) exercise to measure circulating 
leukocytes and inflammatory markers (IL-6, IL-1β, IL-1ra, and 
MCP-1). For the 48-h prior to all testing procedures, partici-
pants were required to abstain from strenuous physical activity. 
Furthermore, 10  h prior to testing participants underwent an 
overnight fast, which also included abstinence from cigarette 
smoking, caffeine, and alcohol (as confirmed from self-reported 
diaries).
TaBle 1 | Mean baseline anthropometric, biochemistry, aerobic fitness, and smoking variables within the smoking (n = 27; YsM = 14, MsM = 13) and 
non-smoking (n = 27; Yns = 14, Mns = 13) populations.
anthropometric data Young smokers Young non-smokers Middle-aged smokers Middle-aged non-smokers
Age (years) 22.00 ± 1.57 22.00 ± 1.60 33.00 ± 7.75* 36.00 ± 6.59#
Height (cm) 182.00 ± 0.07 182.00 ± 0.06 177.00 ± 0.07 178.00 ± 0.06#
Weight (kg) 81.78 ± 12.07 86.88 ± 16.5 81.22 ± 12.87 90.83 ± 14.51
VO2 peak (mL. kg−1. min−1) 36.67 ± 2.94 39.27 ± 6.06 33.93 ± 8.42 31.62 ± 5.96
Waist to hip ratio 0.86 ± 0.05 0.85 ± 0.10 0.86 ± 0.06 0.91 ± 0.07#
SBP (mmHg) 113.64 ± 9.79 106.71 ± 28.54 116.27 ± 10.08 116.75 ± 9.28
DBP (mmHg) 69.46 ± 9.10 69.29 ± 9.54 76.80 ± 8.91 77.77 ± 8.63
Heart rate (bpm) 69.14 ± 11.02 75.33 ± 11.26 65.43 ± 12.45 66.62 ± 8.26
% Fat mass 15.62 ± 5.78 17.5 ± 8.14 24.75 ± 6.76* 26.51 ± 4.96#
Lean mass (kg) 63.0 ± 9.05 65.55 ± 12.12 59.02 ± 6.61 61.23 ± 5.90
Fat mass (kg) 12.37 ± 5.32 18.22 ± 10.15 20.68 ± 6.83* 24.96 ± 7.01
Biochemistry
CRP (mg/L) 2.00 ± 1.89 0.92 ± 0.52* 1.98 ± 1.79 1.30 ± 0.92
HDL (mmol L−1) 1.06 ± 0.034 1.19 ± 0.27 1.22 ± 0.36 1.12 ± 0.25
Triglycerides (mmol L−1) 1.28 ± 0.64 0.99 ± 0.33 1.50 ± 0.84 1.28 ± 0.37#
Fasting glucose (mmol L−1) 4.21 ± 0.82 5.18 ± 0.55 5.36 ± 0.40 4.53 ± 0.90
smoking variables
Smoking history (years) 5.21 ± 1.71 14.62 ± 6.29
Pack-years 2.86 ± 1.72 12.15 ± 9.08
Cigarettes/day 12.31 ± 6.54 15.79 ± 7.33
Fagerstrom dependence score 2.31 ± 1.32 2.64 ± 1.28
*Denotes statistically different to YSM (P < 0.05).
#Denotes statistically different to YNS (P < 0.05).
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Baseline Testing
Participants reported to the laboratory between 0500 and 
0800 h, rested and fasted for a baseline testing session. Stature 
(Stadiometer: Custom CSU, Bathurst, NSW, Australia), body mass 
(HW 150 K, A and D, Bradford, MA, USA), and waist and hip cir-
cumferences (steel tape, EC P3 metric graduation, Australia) were 
obtained for analysis of body composition based on standardized 
techniques (20). Body mass index (BMI) was calculated from 
mass and stature, further waist and hip circumferences provided a 
waist to hip ratio. In addition, a supine dual-energy x-ray absorp-
tiometry (DXA) scan was conducted for the determination of 
body composition (XR800, Norland, Cooper Surgical Company, 
Trumbull, CT, USA). Scanning resolution and speed were set at 
6.5 mm × 13.0 mm and 130 mm s−1, respectively. Whole body 
scans were analyzed (Illuminatus DXA, ver. 4.2.0, USA) for 
total body lean mass and total body fat mass and are reported in 
absolute and relative terms. Resting blood pressure was obtained 
through a commonly used indirect technique involving the use of 
an aneroid sphygmomanometer and stethoscope (Welch-Allyn, 
Arden, NC, USA); furthermore, participants were fitted with a 
HR monitor (Rs800cx, Vantage NV, Polar, Finland) to obtain a 
measure of resting HR. Additionally, a baseline blood sample 
was collected to determine fasting glucose, total cholesterol, and 
baseline immune and inflammatory markers.
Participants also performed a graded exercise test (GXT) 
on an electronically braked cycle ergometer (LODE Excalibur 
Sport, LODE BV, Groningen, The Netherlands) for the deter-
mination of VO2peak. In order to accommodate different likely 
physical capacities, the younger population began the incre-
mental GXT at 100  W and increased by 25  W every minute 
until volitional exhaustion, whereas the middle-aged popula-
tion began the GXT at 25 W and increase 25 W every minute. 
HR was obtained every minute and a session RPE (Modified 
Borg CR10 scale) was collected at completion of the GXT. 
Pulmonary gas exchange was measured by determining O2 and 
CO2 concentrations and ventilation to calculate VO2 using a 
metabolic gas analysis system (Parvo-Medics, True2400, East 
Sandy, UT, USA). The system was calibrated according to the 
manufacturer’s instructions. This involved the pneumotachom-
eter calibration using a 3-L syringe. The gas analyzers were 
calibrated using a two-point fully automated process involving 
room air and gas calibration for fractional gas concentration 
with a gravimetric gas mixture of known concentrations [CO2, 
4.1% (0.1); O2, 15.7% (0.2)].
experimental Protocol: acute exercise
Following the baseline session, participants reported to the labo-
ratory in a fasted and rested state for the completion of the exercise 
protocol that consisted of 40 min of stationary cycle ergometry 
(Monark 828E, Monark Exercise AB, Varburg, Sweden) at 50% 
of VO2peak. The workload was calculated as 50% of the pedaling 
resistance (Watt) achieved during the GXT and was converted 
into kilopond units and set as a fixed intensity for the exercise 
protocol. The selection of this exercise protocol was based on pre-
vious research (21) that demonstrated an inflammatory response 
to an acute bout of exercise of the same intensity and duration 
as the current study, yet within the tolerable limits for middle-
aged participants of lower fitness capacities. Telemetry-based HR 
(Rs800cx, Vantage NV, Polar, Finland) and RPE were recorded 
every 5 min during the exercise protocol.
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Blood collection
Venous blood was collected pre- and post- (0  min, 1, and 
4 h) exercise via a 20-guage catheter inserted into the medial 
antecubital vein. Approximately 40 mL of blood was collected 
and aliquoted into serum separator tubes (SST) for analysis 
of baseline blood lipid profile and CRP, ethylene diamine 
tetraacetic acid (EDTA) tubes for analysis of IL-6, IL-1ra, 
IL-1β, MCP-1, glycosylated hemoglobin (HbA1c), glucose, 
lactate, and total and sub-population leukocyte count. EDTA 
tubes were centrifuged immediately post-aliquot at 3500 rpm 
for 15  min at 4°C, and SST tubes were left to clot at room 
temperature for 20 min prior to centrifugation. Supernatants 
were immediately stored at −80 and −20°C for EDTA and SST, 
respectively.
Blood analysis
Blood samples were analyzed for blood lipid profile, CRP, IL-6, 
IL-1ra, IL-1β, MCP-1, and total and sub-population leukocyte 
count. Total cholesterol was analyzed using an enzymatic 
method and polychromatic endpoint technique measurement 
(Dimension Xpand Plus, Siemens Healthcare Diagnostics, 
Sydney, NSW, Australia). HDL cholesterol was measured using 
accelerator selective detergent methodology. Triglycerides were 
assessed using an enzymatic method and biochromatic endpoint 
technique measurement. Furthermore, HbA1c was measured 
using automated high-performance liquid chromatography 
methodology (Bio-Rad Variant, Bio-Rad Laboratories, Sydney, 
NSW, Australia). Leukocyte count was determined by a cell 
counter (Sysmex XT-1800i, Mundelein, IL, USA). Moreover, 
concentrations of CRP were determined using a solid phase, 
chemiluminescent immunometric assay, and concentrations of 
IL-6, IL-1ra, IL-1β, MCP-1, and were analyzed with a sandwich 
enzyme immunoassay technique, according to manufacturer’s 
instructions (ELISAkit, Melbourne, VIC, Australia and Merk 
Millipore, Billerica, MA, USA). The lower limit of quantification 
for the IL-6, IL-1ra, IL-1β, and MCP-1 assays were 0.9, 8.3, 0.8, 
and <10 pg/mL, respectively.
statistical analysis
All data are reported as mean  ±  SD. Normal distribution 
was determined by Shapiro–Wilk’s test, and non-normally 
distributed data (inflammatory data) were logarithmically 
transformed prior to analysis. Repeated measures analysis of 
variance (ANOVA) was used to determine within- and between-
group differences (YSM vs. YNS, MSM vs. MNS, smokers and 
non-smokers). Where a group interaction resulted, simple main 
effects test were applied to determine the source of significance. 
Significance was set at P  <  0.05. All statistical procedures 
were performed using Predictive Analytic Software (PASW) 
(Statistical Package for the Social Sciences for Windows version 
18.0, Chicago, IL, USA). An a priori power analysis was com-
pleted using G*Power (G*Power for Windows, version 3) based 
on data obtained from previous similar studies. The output 
parameters demonstrate a sample size of 16 to provide actual 
power of 0.67, and as such we recognize the potential limitation 
of reduced power of this study.
resUlTs
Baseline variables for body composition, blood lipid profile, 
anthropometric, and smoking variables are reported in Table 1. 
The MSM had significantly greater smoking history in terms of 
years of smoking and pack years (P <  0.05), but did not differ 
in terms of dependence level (FTND). The middle-aged cohort 
(MSM, MNS) demonstrated higher absolute (SM) and relative fat 
mass (SM and NS) than their younger counterparts (P < 0.05). As 
expected, there were significant differences for age between the 
middle-aged and young groups (P < 0.05), although no differences 
were evident for VO2peak (P > 0.05). For the 40-min cycle ergometry 
bout, exercise-induced HR responses (% of HRmax) were not signifi-
cantly different between groups (74.2 ± 9.7, 75.6 ± 4.9, 79.6 ± 5.1, 
and 78.6 ±  7.2% for YSM, MSM, YNS, and MNS, respectively, 
P > 0.05). Furthermore, there were no significant differences in 
session RPE between groups (5.3 ± 1.6, 4.5 ± 1.8, 4.8 ± 1.5, and 
4.5 ± 1.4% for YSM, MSM, YNS, and MNS, respectively, P > 0.05).
Young smokers and non-smokers
Inflammatory responses of IL-6, IL-1β, MCP-1, and IL-1ra are 
presented in Figure 1. YSM showed higher IL-1ra than YNS at 
baseline (P < 0.05), though no further baseline differences were 
evident. In response to an acute bout of exercise, YSM showed an 
amplified IL-6 response from immediately- to 1 h post compared 
to YNS (P < 0.05), alongside significantly higher IL-1ra values 
across all time points (P < 0.05). Furthermore, IL-1β was elevated 
at 1 h post-exercise in YSM (P < 0.05), which was not observed 
in YNS (P > 0.05). Moreover, the YSM group observed within-
condition increases in IL-6, MCP-1, and IL-ra post-exercise 
(P < 0.05), and although IL-1ra values decreased from 1 to 4 h, 
they remained above pre-values (P  <  0.05). Similarly, values 
for MCP-1 declined in YSM, as well as the YNS, from 1 to 4 h 
(P < 0.05). YNS observed a decline in IL-6 values from post to 
1 h post (P < 0.05), although no significant within change was 
observed for IL-1ra in YNS, values were elevated above that pre-
values at 4 h post-exercise (P < 0.05).
There were no differences between YNS and YSM at baseline 
or across the protocol for total leukocyte count, neutrophils, 
platelets, monocytes, or eosinophils (P > 0.05; Figure 2). YSM 
had higher concentrations of lymphocytes at 1  h post-exercise 
compared to YNS (P <  0.05), although basophils were higher 
at 1 and 4 h post-exercise in YNS compared to YSM (P < 0.05). 
Both YSM and YNS observed respective within-group increases 
in total leukocytes from pre- to post-exercise, a prolonged 
post-exercise elevation (1–4  h) in YNS (P <  0.05). Similarly, 
both YSM and YNS observed post-exercise elevation in platelets 
(P < 0.05), followed by a decline at 1 h (P < 0.05) and an increase 
thereafter (P <  0.05). All groups observed post-exercise eleva-
tions in neutrophil concentrations, which remained elevated at 
4 h-post exercise (P < 0.05). YNS showed increased post-exercise 
lymphocyte concentrations that were not observed in the YSM 
cohort. Monocytes for YNS increased post-exercise followed by 
a decline thereafter, while YSM values were below pre-values at 
4 h post-exercise (P < 0.05). Basophils and eosinophils for YSM 
and YNS both resulted in declines from post-exercise (P < 0.05).
FigUre 1 | Mean ± sD inflammatory responses for il-6, il-1ra, il-1β, 
and McP-1 pre, post, 1 and 4 h post exercise for younger and 
middle-aged smokers and non-smokers.  *represents significantly 
different between YSM and YNS (P < 0.05), # represents significantly 
between MSM and MNS (P < 0.05), ¥ represents significantly different 
between YSM and MSM (P < 0.05). ¤ represents significantly different 
between YNS and MNS (P < 0.05). Within changes for YSM, YNS, MSM, 
and MNS are represented by (a–D), respectively (P < 0.05).
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Middle-aged smokers and non-smokers
At baseline, MSM had lower IL-6 when compared to MNS 
(P < 0.05). Exercise induced no within-group changes for IL-6 
in either MSM or MNS. Both groups observed post-exercise 
increases in IL-1β followed by a decline to 1  h (P  <  0.05); 
however, MSM experienced marginal elevations in post-exercise 
IL-1β (Post-4 h) (P < 0.05). Furthermore, both MNS and MSM 
observed post-exercise elevations in MCP-1 (P <  0.05), which 
remained elevated to 1 h for MNS (P < 0.05), though declined 
for MSM (P < 0.05). Finally, MNS observed an increase in IL-1ra 
post exercise, which remain elevate above pre at 4 h post-exercise 
(P < 0.05) that was not observed in MSM (P > 0.05).
There were no baseline differences for neutrophils or platelets 
in the middle-aged cohort (P  >  0.05). Total leukocyte count 
was higher at baseline for MSM compared to MNS (P > 0.05). 
Furthermore, MSM demonstrated higher lymphocyte concen-
trations at baseline and 1 and 4  h post-exercise (P >  0.05). In 
addition, MSM had higher concentrations of monocytes and 
basophils at baseline and 4 h post-exercise (P > 0.05) compared to 
MNS. Moreover, eosinophils for MSM were elevated above MNS 
at 4 h post-exercise (P > 0.05). Both MSM and MNS observed 
a within-group increase in total leukocytes from pre- to post-
exercise (P < 0.05), which was further increased from 1 to 4 h 
post-exercise (P < 0.05). Similarly, MNS observed post-exercise 
elevation in platelets (P <  0.05) followed by a decline at 1  h 
(P <  0.05), which was not observed in MSM (P >  0.05). Both 
MNS and MSM showed post-exercise elevations in neutrophil 
concentrations, which remained elevated 4  h-post exercise 
(P < 0.05). MNS showed increases in lymphocyte concentrations 
post-exercise, not observed in the MSM cohort, who experienced 
a decline post-exercise (post-1  h) followed by an increase at 
4 h (P < 0.05). Monocytes for MNS and MSM increased post-
exercise followed by a decline thereafter (P <  0.05). Basophils 
for MNS increased post-exercise, yet MSM decline from post 
to 1 h (P < 0.05). Finally, eosinophils for MNS increased post-
exercise, however, declines were observed post exercise for MSM 
(post–1 h) (P < 0.05).
smokers
For the smoker cohort, MSM had higher IL-1β at baseline 
when compared to YSM; moreover, IL-1ra values were greater 
for YSM at baseline (P <  0.05); yet, IL-1β and MCP-1 were 
higher at 4  h post-exercise for MSM than YSM (P <  0.05). 
There were no between-group differences for YSM and MSM 
for total leukocyte count, platelet, or neutrophils (P > 0.05). 
However, MSM demonstrated higher lymphocytes and mono-
cytes at 4 h post-exercise (P < 0.05). Furthermore, eosinophils 
were higher in MSM at baseline and 1 and 4 h post-exercise 
(P < 0.05) and basophils were higher in MSM across all time 
points (P < 0.05).
non-smokers
MNS had higher IL-6 at baseline than YNS, while no baseline 
differences were evident MCP-1, CRP, IL-1β, or IL-1ra for the 
two non-smoking groups (P < 0.05). Exercise-induced elevations 
in IL-6 in MNS (1 and 4 h) were greater than YNS (P < 0.05). 
Furthermore, a greater post-exercise (4 h post) increase in IL-1ra 
was evident in MNS compared to YNS (P < 0.05). There were no 
between-group differences for total leukocyte count neutrophils, 
lymphocytes, monocytes, or eosinophils between MNS and YNS 
(P > 0.05). Platelets at 4 h were higher in YNS, as were basophils 
at 1 h post-exercise (P > 0.05).
FigUre 2 | Mean ± sD total and sub-population leukocyte count pre, post, 1- and 4-h post exercise for younger and middle-aged smokers and 
non-smokers. *represents significantly different between YSM and YNS (P < 0.05), # represents significantly between MSM and MNS (P < 0.05), and ¥ represents 
significantly different between YSM and MSM (P < 0.05). ¤ represents significantly different between YNS and MNS (P < 0.05). Within changes for YSM, YNS, MSM, 
and MNS are represented by (a–g), respectively (P < 0.05).
December 2015 | Volume 6 | Article 6346
Kastelein et al. Exercise-Induced Inflammatory Response in Smokers
Frontiers in Immunology | www.frontiersin.org
DiscUssiOn
This study demonstrated the effects of acute exercise on mark-
ers of immune and inflammatory function in smokers and 
non-smokers and between longer (MSM) and shorter (YSM) 
smoking history. Accordingly, middle-aged smoker’s exhibit 
elevated basal concentrations of MCP-1 than their age-matched 
non-smoker counterparts and a younger smoker group, which 
increases with smoking history and may indicate smoking 
associated endothelial injury and future systemic disease risk. 
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Furthermore, a novel finding of this study is the marked dif-
ferences between smokers and their non-smoker counterparts; 
specifically, while exercise had a stimulatory effect on markers 
of inflammation for YSM and MSM, an amplified response was 
evident in YSM. Contrastingly, the post-exercise leukocyte 
response was greater in MSM compared to YSM and non-
smokers, suggestive of immune and inflammatory changes 
reflective of smoking history.
Tobacco smokers are predisposed to an array of non-
communicable diseases, with this susceptibility thought to arise 
through alterations in immune and inflammatory process from 
the repeated exposure to tobacco smoke (22–24). As evidence, 
immunosuppression and a heightened inflammatory profile 
consistent with smoking history are common features observed 
in chronic tobacco smokers (4, 6). However, the complexity of 
the composition of tobacco smoke in addition to factors, such 
as smoking duration, frequency, gender, and environmental fac-
tors, poses difficulty when interpreting immune-inflammatory 
system responses (2, 25–27). As evidence, Kuschner et  al. (5) 
revealed that concentrations of MCP-1, IL-1β, IL-6, TNF-α, 
and IL-8 were elevated in the bronchoalveolar lavage (BAL) of 
smokers when compared to non-smokers. Findings from the 
present study demonstrate that smokers have elevated basal 
concentrations of the chemokine MCP-1 in peripheral blood, 
which is linked to inflammatory cell recruitment and has been 
previously demonstrated in the pulmonary microenvironment 
(28). However, elevations in MCP-1 in chronic smokers as 
observed in the present study may be associated with the inflam-
matory load linked to long-term smoking and could reinforce 
the relationship between smoking and immune and inflamma-
tory alterations.
In addition to elevations in inflammatory cytokines, elevated 
concentrations of circulating leukocytes have been implicated as 
a predictive marker of lifestyle-related disease (29, 30). Smoking 
is reported to elevated leukocyte count, with Frohlich et al. (4) 
reporting white blood cell (WBC) count to be positively associ-
ated with smoking status in men. Furthermore, Kawada (31) 
reported current smokers to have elevated WBC count above 
that of non-smokers. The present study also demonstrated 
higher baseline WBC in the MSM group, along with elevated 
basal concentrations of lymphocytes and monocytes. In agree-
ment with previous literature (4, 31), the current findings 
suggest that prolonged exposure to smoking insult can induce 
elevated total and fractional leukocyte counts, and escalate the 
inflammatory risk.
While the effects of long-term smoking are well established, 
less well known are the effects of exercise in a smoker popula-
tion, particularly given the supposed important role exercise 
has as an anti-inflammatory mediator. A novel finding from 
this study is that YSM demonstrated a greater exercise-
induced inflammatory response than YNS, as evidenced by 
the observed elevations in IL-6 and IL-1ra. Interestingly, YSM 
also exhibited a greater peak in IL-1β at 1 h post compared to 
YNS. To explain these counter-intuitive observations, post-
exercise declines in IL-1ra and increased IL-1β at 1  h may 
be a result of receptor availability, as when concentrations of 
IL-1ra decline, IL-1β is able to bind with the IL-1 receptor 
and exert subsequent biological actions (32). Regardless, the 
current study indicates that a moderate-intensity exercise 
stimulus was not sufficient to induce a significant inflamma-
tory response in healthy non-smokers; hence, future studies 
should consider a higher intensity to induce a greater cytokine 
response in non-smokers. Furthermore, chronic exposure 
to tobacco smoke may prime immune and inflammatory 
cells in YSM (33), thereby inducing a greater inflammatory 
response to a similar exercise stimulus. However, an observed 
immunosuppression seems evident in MSM, and thus an 
inhibition of the exercise-induced inflammatory response was 
evident (14).
An acute bout of exercise is suggested to elicit an influx of 
cytokines with anti-inflammatory actions (12); interestingly, 
the magnitude of response in MSM was lower than YSM for 
the same exercise stimulus. More specifically, MSM observed 
elevated IL-1β without concurrent elevations on IL-1ra or IL-6, 
which is suggestive of a delayed or compromised immune-
inflammatory response to exercise. The present study suggests 
that MSM have elevated IL-1β, and furthermore, that the typi-
cal inflammatory response of elevated IL-1ra and IL-6 (12) to 
exercise was not observed. It could be hypothesized that such 
changes to the inflammatory profile and response in MSM may 
be attributed to changes in the T-helper (Th)-1 and T-helper 
(Th)-2 cytokine balance. The Th-1/Th-2 cytokine balance 
theory implicates Th-1- and Th-2-derived cytokines in the 
regulation of homeostatsis; chronic tobacco smoke exposure 
is suggested to cause a shift in the cytokine balance, and thus 
immune regulation (34, 35). Moreover, long-term smoking 
is suggested to induce alterations to the responsiveness of 
the hypothalamic–pituitary–adrenal (HPA) axis (14, 36). 
The containment of inflammation is partly mediated by the 
HPA axis; consequently, a smoking-induced decrease in the 
responsiveness of the HPA axis may promote the disinhibition 
of immune and inflammatory reactions (36). Although these 
mechanisms were not measured in the current study, they may 
provide explanation for the compromised anti-inflammatory 
response to exercise observed in MSM.
Regulatory immune and inflammatory mediators are known 
to increases in response to an exercise stimulus (7, 37), par-
ticularly, circulating leukocytes neutrophils, lymphocytes, and 
monocytes are reported in increase in a biphasic fashion (7, 37). 
In the present study, MSM demonstrated greater concentrations 
of lymphocytes, basophils, and monocytes post-exercise than 
young smokers and non-smokers. By contrast, Ceddia et al. (38) 
reported attenuated leukocytosis in response to maximal exercise 
in older vs. younger participants – although no literature exists 
on the effects of smoking on such responses. Moreover, YSM 
demonstrated higher lymphocytes at 1 h post-exercise but lower 
basophils until 4 h post-exercise compared with YNS. Circulating 
leukocytes, particularly monocytes are thought to play a central 
role in inducing the acute phase response (37) and are the source 
of the cytokines TNF-α, IL-6, and IL-1. Therefore, it is plausible to 
suggest that changes in circulating leukocytes may be responsible 
for the altered inflammatory response to exercise in a smoker 
population. However, further studies are needed to confirm such 
a hypothesis.
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In conclusion, this present study revealed that smoker’s exhibit 
elevated MCP-1 and IL-1β that seem to be increased with a 
longer smoking history (~15 years). Although such findings may 
be attributed to age, the lack of significant difference among NS 
indicates that possibly such differences between smokers may be 
due to length of smoking history. In response to an acute bout of 
exercise, the SM and NS presented marked differences; specifi-
cally, tobacco smoke may prime circulating leukocytes in YSM, 
resulting in an amplified inflammatory response to the exercise 
stimulus when compared to their NS counterparts. Moreover, the 
immune-inflammatory responses of MSM may indicate an effect 
of chronic exposure, via elevated WBC count and a compromised 
inflammatory response to exercise.
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